Shanghai RAAS (002252.SZ)

Founded in 1988 and headquartered in Shanghai, Shanghai RAAS is the leading blood plasma player in China. The company specializes in the research and manufacture and sale of plasma-derived products for therapeutic use in the areas of immunology, hematology and intensive care medicines. Shanghai RAAS’s shares are publicly listed on China’s Shenzhen Exchange. The company has 41 blood collection centers in 10 provinces in China, with an annual production capacity of more than 1.1 million liters. Shanghai RAAS also operates three fractionation facilities in China with a capacity of 2 million liters and has 11 key products with leadership positions in albumin, IVG and factor VII. *

	Start	1998-01-01 established
	Industry	plasma protein (human)
	Industry 2	blood plasma

	Region	Shanghai
	Country	China
	City	n. a.
		Address record changed: 2019-11-14

Basic data	Employees	n. a.

		* Document for »About Section«: Grifols S.A.. (11/13/19). "Press Release: Grifols and Shanghai RAAS Obtain Authorization for Their Strategic Alliance in China". Barcelona.

		Record changed: 2023-07-10

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Shanghai RAAS (002252.SZ)

[1] Grifols S.A.. (11/13/19). "Press Release: Grifols and Shanghai RAAS Obtain Authorization for Their Strategic Alliance in China". Barcelona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]